Contraception in the cosmos: the combined oral contraceptive pill in space.
نویسنده
چکیده
On 12 April 1961, Yuri Gagarin became the first human to travel into space. His 2-hour voyage aboard the Vostok 3KA-2 definitively demonstrated that humans could survive in space. In the 55 years since Gagarin’s historic flight, hundreds of astronauts and cosmonauts have travelled into space, mankind has visited the moon and it is now realistic to believe that a manned mission to Mars will commence in the foreseeable future. Space is a uniquely harsh environment. The lack of oxygen and presence of microgravity and space radiation predispose astronauts to a wide range of health problems. The microgravity, busy mission schedules and lack of medical equipment make treating acute health problems during spaceflight extremely difficult. Prevention of disease is therefore of the utmost importance and by ensuring astronauts remain healthy, aerospace medicine physicians make a vital contribution to the success of missions into space. The combined oral contraceptive pill (COC) is one medication that could be used to prevent health problems in space. Whilst there is no official requirement for them to do so, the vast majority of the National Aeronautics and Space Administration’s (NASA) female astronauts choose to use the COC whilst in space (P Stepaniak, NASA Flight Surgeon, personal communication, 23 October 2006). Whilst much is known about the physiological effects of the COC on Earth, there has been no discussion of the potential benefits and disadvantages of its use in space. Such a discussion must take into account the effects of spaceflight on human physiology and the fact that modern female astronauts are a highly selected, motivated and, in general, healthy group of individuals. This article aims to review the potential benefits and disadvantages of using the COC during long-duration stays in space. It begins with a discussion of the gynaecological effects of the COC. It then examines how the COC might influence the effects of spaceflight on the human musculoskeletal system. Finally, it explores ways in which the COC could affect other systems of the body in ways that are relevant to spaceflight.
منابع مشابه
بررسی کیفیت استفاده از قرص های ضد بارداری خوراکی در زنان مراجعه کننده به زایشگاه های شهر بیرجند در سال های 76-77
Background and purpose: The number of unintended pregnancies have been increased in many countries. Âfter other ulternative methods, oral contraceptive pills are most widely used method of contraception in Ïran and the other countries in the world. This study was conducted in order to determine the know how in contraceptive pills (continuous use, missed ones and the number of missed pil...
متن کاملImproving combined contraceptive pill/oral contraceptives prescribing in general practice
Introduction Eighty per cent of contraceptive care occurs in the general practice setting. UK Medical Eligibility Criteria provides clear guidelines for the safe provision of appropriate contraception. The Faculty of Sexual and Reproductive Health and the National Institute for Health and Care Excellence offer further recommendations for initiation and continuation of the combined contraceptive...
متن کاملWomen's knowledge of taking oral contraceptive pills correctly and of emergency contraception: effect of providing information leaflets in general practice.
BACKGROUND About one third of all pregnancies are unplanned and 20% of all pregnancies end in abortion. More than 170,000 legal abortions are performed in the United Kingdom annually. Nearly all general practitioners provide contraceptive advice; the most commonly used form of reversible contraception is the oral contraceptive pill. AIM The aim of this study was to determine factors associate...
متن کاملGeneral practice Effect of educational leaflets and questions on knowledge of contraception in women taking the combined contraceptive pill: randomised controlled trial
Objective: To assess whether provision of educational leaflets or questions on contraception improves knowledge of contraception in women taking the combined contraceptive pill. Design: Randomisation of women into three groups according to type of educational leaflet on contraceptive information. These groups were subdivided into two on the basis of questions on contraception asked by the docto...
متن کاملNew Product Review (September 2003). Norelgestromin/ethinyl oestradiol transdermal contraceptive system (Evra).
This new transdermal contraceptive system (contraceptive patch), Evra (Janssen-Cilag), received a UK product licence in 2003. In clinical trials: Consistent doses of norelgestromin and ethinyl oestradiol are released into the systemic circulation daily. Pharmacokinetic data suggest that levels are sufficient to inhibit ovulation for at least 7 days. The overall Pearl index for the contraceptive...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The journal of family planning and reproductive health care
دوره 34 1 شماره
صفحات -
تاریخ انتشار 2008